Vicarious Surgical Inc. Reports Director Departure and Officer Changes
Ticker: RBOTW · Form: 8-K · Filed: Jan 21, 2025 · CIK: 1812173
| Field | Detail |
|---|---|
| Company | Vicarious Surgical Inc. (RBOTW) |
| Form Type | 8-K |
| Filed Date | Jan 21, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50, $10,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, management-change
TL;DR
Vicarious Surgical board shake-up: Director John P. Morgan out, new officers in.
AI Summary
Vicarious Surgical Inc. announced on January 17, 2025, the departure of Director John P. Morgan. The company also reported on the election of new directors and the appointment of certain officers, along with details on compensatory arrangements for these officers. The filing does not specify any financial transactions or dollar amounts related to these changes.
Why It Matters
Changes in board composition and officer appointments can signal shifts in company strategy or governance, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: low — The filing primarily concerns corporate governance changes and does not involve significant financial transactions or operational shifts that would inherently increase risk.
Key Players & Entities
- Vicarious Surgical Inc. (company) — Registrant
- John P. Morgan (person) — Departing Director
- Delaware (jurisdiction) — State of Incorporation
FAQ
Who is the departing director from Vicarious Surgical Inc.?
John P. Morgan is the departing director.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated January 17, 2025.
What are the main items covered in this Form 8-K filing?
The filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
In which state is Vicarious Surgical Inc. incorporated?
Vicarious Surgical Inc. is incorporated in Delaware.
What is the SIC code for Vicarious Surgical Inc.?
The Standard Industrial Classification code for Vicarious Surgical Inc. is 3842, related to Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Filing Stats: 609 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2025-01-21 16:37:24
Key Financial Figures
- $0.0001 — tered Class A common stock, par value $0.0001 per share RBOT The New York Stock E
- $11.50 — mon stock, each at an exercise price of $11.50 per share RBOT WS The New York Stoc
- $10,000 — from January 2, 2025 to June 30, 2025, $10,000 per month, and (ii) during the period f
Filing Documents
- ea0228083-8k_vicarious.htm (8-K) — 28KB
- 0001213900-25-005036.txt ( ) — 242KB
- rbot-20250117.xsd (EX-101.SCH) — 4KB
- rbot-20250117_def.xml (EX-101.DEF) — 26KB
- rbot-20250117_lab.xml (EX-101.LAB) — 36KB
- rbot-20250117_pre.xml (EX-101.PRE) — 25KB
- ea0228083-8k_vicarious_htm.xml (XML) — 6KB
02. Departure of Directors or Certain Officers; Election
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 17, 2025, Vicarious Surgical Inc. (the "Company") entered into a consulting agreement (the "Consulting Agreement") with William Kelly in connection with Mr. Kelly's previously disclosed departure from his role as Chief Financial Officer of the Company. Pursuant to the Consulting Agreement, Mr. Kelly will provide consulting and advisory services to the Company from January 2, 2025 to December 31, 2028. For his services under the Consulting Agreement, Mr. Kelly will receive (i) during the period from January 2, 2025 to June 30, 2025, $10,000 per month, and (ii) during the period from July 1, 2025 to December 31, 2028, an hourly rate. Mr. Kelly's outstanding stock options and restricted stock units granted under the Company's 2021 Equity Incentive Plan, as amended, will continue to vest while Mr. Kelly is providing consulting services to the Company until June 30, 2025, with no additional vesting after June 30, 2025. The Consulting Agreement also includes confidentiality, non-solicitation and other customary provisions. The foregoing description of the Consulting Agreement is not complete and is qualified in its entirety by reference to the full text of the Consulting Agreement, a copy of which the Company intends to file as an exhibit to its Annual Report on Form 10-K for the year ended December 31, 2024. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VICARIOUS SURGICAL INC. By: /s/ Adam Sachs Name: Adam Sachs Title: Chief Executive Officer Date: January 21, 2025 2